{"uniprot":"Q0VAA5","gene":"PLCXD2","name":"PI-PLC X domain-containing protein 2","organism":"Homo sapiens (Human)","status":"dark","length":305,"sequence":"MLAVRKARRKLRMGTICSPNPSGTKTSSEVCNADWMASLPPHLHNLPLSNLAIPGSHDSFSYWVDEKSPVGPDQTQAIKRLARISLVKKLMKKWSVTQNLTFREQLEAGIRYFDLRVSSKPGDADQEIYFIHGLFGIKVWDGLMEIDSFLTQHPQEIIFLDFNHFYAMDETHHKCLVLRIQEAFGNKLCPACSVESLTLRTLWEKNCQVLIFYHCPFYKQYPFLWPGKKIPAPWANTTSVRKLILFLETTLSERASRGSFHVSQAILTPRVKTIARGLVGGLKNTLVHSNRWNSHGPSLLSQERS","function_summary":"A human membrane-proximal scaffold that uses a PLC-like barrel with an embedded X domain to bind and organize phosphoinositide signaling assemblies at the cell surface. Rather than acting as a primary catalyst, it stabilizes complexes that interpret and tune phosphatidylinositol-derived signals, thereby modulating pathway output at the plasma membrane through multivalent protein interactions and lipid-proximal binding.","plain_language":"PLCXD2 has barely been studied. The model's best guess: A human membrane-proximal scaffold that uses a PLC-like barrel with an embedded X domain to bind and organize phosphoinositide signaling assemblies at the cell surface. Rather than acting as a primary catalyst, it stabilizes complexes that interpret and tune phosphatidylinositol-derived signals, thereby modulating pathway output at the plasma membrane through multivalent protein interactions and lipid-proximal binding.","uniprot_summary":"May not be a phospholipase C.","go_terms":{"molecular_function":[{"id":"GO:0005515","label":"protein binding"}],"biological_process":[{"id":"GO:0048015","label":"phosphatidylinositol-mediated signaling"}],"cellular_component":[{"id":"GO:0005886","label":"plasma membrane"}]},"interpro":[{"id":"IPR017946","name":"PLC-like phosphodiesterase, TIM beta/alpha-barrel domain superfamily","type":"homologous_superfamily","start":27,"end":279},{"id":"IPR000909","name":"Phosphatidylinositol-specific phospholipase C, X domain","type":"domain","start":42,"end":214},{"id":"IPR051057","name":"Phosphoinositide phospholipase C domain-containing protein","type":"family","start":17,"end":292},{"id":"IPR042158","name":"PI-PLC X domain-containing protein 1/2/3","type":"family","start":39,"end":291}],"reasoning":"I begin with the InterPro architecture. The core scaffold is IPR017946 (PLC-like phosphodiesterase, TIM beta/alpha-barrel domain superfamily, residues 27–279), a catalytic barrel fold characteristic of phosphoinositide-processing enzymes. Nested within this scaffold lies IPR000909 (Phosphatidylinositol-specific phospholipase C, X domain, residues 42–214), the hallmark X domain that organizes substrate recognition and catalysis in PLC-like proteins. Two family-level signatures reinforce this identity and specificity: IPR051057 (Phosphoinositide phospholipase C domain-containing protein, residues 17–292) and IPR042158 (PI-PLC X domain-containing protein 1/2/3, residues 39–291). The ordered layout—an N-to-C PLC-like barrel embedding an X domain—creates a binding-and-positioning platform that typically engages phosphoinositide headgroups and coordinates metal-assisted chemistry. In this particular architecture, the presence of the X domain within a PLC-like barrel without additional catalytic modules often yields a pseudoenzyme that prioritizes high-affinity binding and scaffolding over hydrolysis.\n\nThis domain architecture causally dictates molecular function as multivalent protein association rather than robust catalysis. The PLC-like barrel and X domain provide a rigid cradle for lipid-proximal protein interfaces, favoring assembly of signaling complexes. This supports GO:0005515 protein binding as the operative molecular function, with binding surfaces tuned by the X-domain topology and the TIM beta/alpha-barrel.\n\nFrom this binding-centric chemistry, the biological role follows: organizing phosphoinositide-driven pathways. By docking to phosphoinositide substrates and recruiting effectors, the protein modulates the flux and interpretation of PI-derived signals. This places it squarely in GO:0048015 phosphatidylinositol-mediated signaling, where it likely tunes second-messenger production and downstream effector engagement rather than directly cleaving phosphoinositides.\n\nCellular placement is inferred from the need to access membrane-embedded phosphoinositides and the observed membrane-proximal scaffolding. The architecture lacks transmembrane helices but is optimized for peripheral membrane association via lipid- and protein-mediated targeting, which situates the protein at the GO:0005886 plasma membrane. This location enables efficient coupling to membrane-resident lipid pools and receptor-proximal assemblies.\n\nMechanistically, I hypothesize that the PLC-like barrel and X domain assemble a membrane-proximal hub that binds phosphoinositide-rich patches and recruits signaling partners. By stabilizing complexes that include active phosphoinositide-processing enzymes and their effectors, it can bias pathway output without direct catalysis. Likely partners include receptor-proximal adaptors and active phosphoinositide-modifying enzymes at the plasma membrane, where cooperative assemblies fine-tune signal amplitude and duration.","category":"dark","control_evaluation":null,"validation_plan":null,"structure":{"source":"AlphaFold DB","pdb":"/structures/AF-Q0VAA5.pdb","alphafold":"https://alphafold.ebi.ac.uk/entry/Q0VAA5"},"links":{"uniprot":"https://www.uniprot.org/uniprotkb/Q0VAA5/entry","atlas":"/p/Q0VAA5"},"provenance":{"model":"BioReason-Pro (ESM3 esm3-sm-open-v1)","source_list":"Pharos Tdark","note":"AI prediction, not experimentally verified"}}